In pneumonia local phagocyte activation is crucial for clearing of pathogenic microorganisms. In this context alveolar macrophage intedeukin-8 secretion, phagocyte oxidative response and concentrations of lavage proteins were quantified, including interleukin-8, in 31 patients with pneumonia, 13 age matched patients with peripheral lung consolidation and six healthy volunteers; these findings were related to the impairment of gas exchange and the bacterial load in the alveolar space. Increased interleukin-8 levels were found in bronchoaiveolar lavage fluid (BALF) and in alveolar macrophage supernatants from patients with pneumonia (214 ng/105 AM ± 121 vs 71 ng/105 AM ± 35 and 66 ng/105 AM ± 30, p < 0.05). Interleukin-8 release from alveolar macrophages correlated with the upregulated spontaneous luminol enhanced oxidative response of pulmonary phagocytes but not with the neutrophil count in BALE In pneumonia patients a significant difference was found between patients with 10 4 or more colony forming units (CFU)/ml BALF of one pathogen and patients with less CFU or nonspecific microbiological results (261 ng/105 AM ± 89 vs 179 ng/105 AM ± 81 and 7.5 ng/ml BALF ± 17 vs 0.44 ng/ml BALF ± 1, p < 0,05). Further, a negative correlation between interleukin-8 release of alveolar macrophages and the arterial pO 2 at the time of BALF could be demonstrated (r = -0.47, p < 0.05). The results demonstrate local cellular activation in community-acquired pneumonia, which is related to the bacterial load in the alveolar space and to impairment of gas exchange. This is consistent with the hypothesis that pulmonary phagocytes play a central role in the pathogenesis of bacterial pneumonia, contributing not only to bacterial dearing but also to local tissue damage.
Introduction
Bacterial pneumonia is still a severe infectious disease with considerable mortality despite the advent of potent antimicrobial chemotherapeutics. In this context local phagocyte activation seems to be crucial for effective bacterial killing [1, 2] , which is exemplified by chronic granulomatous disease, a congenital disorder with deficient phagocyte function and recurrent purulent infections including pneumonia [3] . However, this inflammatory process, which is primarily limited to the infected organ can, if not adequately terminated, lead to sepsis and multiorgan failure [4, 5] . Prognostic indicators, which can be quantified in an early phase of disease when infection is still compartmentalized and which are correlated to disease severity and outcome are needed. Since alveolar macrophages are the principal resident phagocytes in the airways they are thought to play an important role in the initial phase of host response. It is evident that small amounts of inhaled bacteria are eradicated effectively by alveolar macrophages. With increasing virulence and numbers of microorganisms a rapid neutrophil influx occurs to combat invading bacteria [6, 7] . In this context a variety of chemokines have been identified, which recruit neutrophils to the lung [8] . Among them interleukin-8 appears to play a central role [9] . High interleukin-8 levels in the alveolar space have been associated with neutrophil influx into the pulmonary compartment under various conditions [10] [11] [12] . It could further be demonstrated that interleukin-8 is of some prognostic value in patients at risk of adult respiratory distress syndrome (ARDS) [13] or in AIDS-associated Pneumocystis carinii pneumonia [14] . In this study we focused on nonventilated patients with community-acquired pneumonia. The aim was to elucidate the state of cellular immunological activation in the alveolar compartment in patients who underwent bronchoscopy and bronchoalveolar lavage (BAL) for microbiological diagnosis. We quantified alveolar macrophage interleukin-8 secretions as well as interleukin-8 levels in BALF together with other'parameters of phagocyte funetion such as oxidative response, the concentration of neutrophil secretion products and markers of alveolo-endothelial membrane integrity, relating our findings to clinical disease severity and lung functional impairment.
Patients and Methods
Patients: A total of 36 patients, admitted to our hospital with community-acquired pneumonia were included in this study. The diagnosis of pneumonia was based on clinical symptoms and laboratory signs of infection (fever > 38°C, purulent sputum, elevated ESR, C-reactive protein and white blood cell count), together with the presence of new or progressing opacities on chest radiograph. The average age of the patients was 51 years with a range of 27-74 years. Seventeen were male, 19 female. Thirteen patients were immunocompromised for various reasons (hematologic malignancy: n = 3, renal transplantation: n = 4, cytotoxic therapy for systemic vasculitis: n = 6). Patients who had received antibiotic treatment before admission (n = 19), were bronchoscopically evaluated after a 24 h discontinuation of therapy, if possible. Patients without prior antibiotic therapy were evaluated within 24 h after admission. Thirteen patients who underwent bronchoscopy for evaluation of peripheral lung consolidation (nine male, four female, mean age 54 years), who had no clinical signs of local or systemic inflammation were accepted as age matched controls. In addition, six healthy nonsmoking volunteers were studied. None of our patients died. To quantify impairment of gas exchange all individuals had blood gas analysis on the day of BAL. Informed consent was obtained from all patients and controls and the study of healthy volunteers was approved by the ethical committee of Lt~beck Medical University.
BronchoalveoIar lavage: Bronchoalveolar lavage was performed with a flexible fibreoptic bronchoscope under standard conditions. Briefly, a total of 100-140 ml prewarmed normal saline was injected in 20 ml aliquots into the lobe of interest with immediate vacuum aspiration after each aliquot. Mean recovery in the patients and age matched controls was 65% with a range from 35%-80% and 80% (75%-90%) in healthy volunteers. The first aliquot, which is known to represent material contaminated with bronchial secretions, was discarded. Another sample was used for quantitative microbiological cultures [15] and remaining portions were pooled. After enumeration of total cell count and cell differentials five patients with a neutrophil percentage of greater than 50% were excluded from this study. Lavage cells were washed twice and resuspended at a density of 106 viable AM/ml in M199 supplemented with 5% fetal calf serum (FCS) and penicillin/streptomycin. Endotoxin contamination was less than 25 pg/ml (M199) or 100 pg/ml (FCS), as determined by the limulus amebocyte lysate assay.
Interleukin-8:Interleukin-8 was quantified in BALF and in the supernatants of alveolar macrophages. For collection of supernatants alveolar macrophages were seeded at a density of 106/ml into 96-well flat bottom microtiter plates for 3 h at 37°C, allowing the cells to adhere. Nonadherent cells were removed by gentle washing with warm cell culture medium. After another incubation period of 16 h supernatants from triplicate wells were removed, pooled and immediately frozen at -80°C until use. Interleukin-8 was determined by a sandwich ELISA using commercially available antibodies. Briefly, 96-well flat bottom microtiter plates were covered with a polyclonal goat anti-IL-8 antibody over night (R&D Systems, USA). After washing and blocking of nonspecific binding sites supernatants from AM were diluted 1:50 and incubated for 4 h. BALF was used undiluted in this assay. A commercially available monoclonal anti-IL-8 antibody (clone 6217.11, R&D Systems) was used as capture antibody and the reaction was quantified photometrically at 405 nm using ABTS as substrate. Recombinant human interleukin-8 (R&D CAP I = pneumonia in immunocompetent patients, n = 18; CAP II = pneumonia in the immunocompromised host, n = 13 and controls, Co I = age matched patients with noninfectious lung disease, n = 13; Co II = healthy volunteers, n = 6, PMN = polymorphonuclear leukocytes.
Systems) was used to produce a standard curve. Lower detection limit of this assay was 0.05 ng/ml. Inter-and intraassay variations were 8% and 7%, respectively.
Chemiluminescence: Chemiluminescence was determined in 4-ml polystyrene tubes containing 105 viable pulmonary phagocytes (alveolar macrophages + PMN) in PBS after amplification with different bystander substrates as previously described [16] : Luminol reacts with products of the MPO/H202/halide system which is expressed by neutrophils and absent in the mature macrophage [17] , lucigenin reacts preferentially with superoxide anion [18] . In all patients the spontaneous and phorbolmyristate acetate (PMA)-stimulated chemiluminescence of pulmonary phagocytes was quantified on an automatic luminometer (Berthold LB 953). Peak concentrations of chemiluminescence, which were reached after 8-15 min were taken for calculation and results are expressed as counts per min.
Proteins: Concentrations of albumin, myeloperoxidase, lactoferrin and fibronectin in BALF were measured by immunoluminometric assays as previously described [19, 20] .
Data analysis: Nonparametric statistics were used throughout this study. Differences between the different groups were compared by the Mann-Whitney U-Test. Correlations were made with the Spearman rank correlation. A p-value of less then 0.05 was considered significant.
Results

Lavage Cell Counts and Microbiology
As expected, all patients with pneumonia had a neutrophil alveolitis with a mean neutrophil count of 16%. Details of the lavage cell differentials are outlined in Table 1 . Quantitative microbiological cultures were available in 29 patients. The causative microbial agent could be identified in 17 patients. Among them we found significant culture results (104 or more CFU/ml) for pneumococci (n = 3),
Haemophilus influenzae (n = 2), B streptococcus (n = 1),
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Pseudomonas aeruginosa (n = 4) and other gram-negative bacilli (n = 5). In addition, in two patients we found other <~ ,150 pulmonary pathogens (Mycoplasma pneumoniae n = 1, Pneumocystis carinii n = 1). In two patients polymicrobial ~ 350 infection was detected. In the other 14 patients the aetio-~ 250 logic agent could not be established as lavage microbiolo-~, gy was either sterile, held a yield of less than 104 CFU/ml ~ 150 or consisted of mixed throat flora. Of those patients 12 had received prior antibiotic therapy.
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Interleukin-8 -50
Alveolar macrophages from all individuals released measurable amounts of interleukin-8 after an overnight incubation period with a range from 39 to 521 ng/105 AM. Interleukin-8 production from patients with pneumonia was significantly upregulated as compared to age matched and healthy controls (p < 0.05). In patients who were immunecompromised, macrophage interleukin-8 secretion was lower than in the immunocompetent group (p < 0.05).
There was no statistically significant difference between the two control groups (Figure 1 ). In BALF interleukin-8 lEE levels were significantly higher in patients with pneumonia ,_, as compared to age matched controls (3.66 ng/ml + 11 vs E 0.089 ng/ml + 0.09, p < 0.05). Interleukin-8 levels in BALF o of all healthy volunteers was below the detection limit of ~ 1E,' the assay. No correlation between macrophage interleu-"a~ kin-8 release or interleukin-8 levels in BALF and neutrophil count could be established.
Phagocyte Chemiluminescence
In all patients high phagocyte oxidant production, as measured by basal and stimulated luminol enhanced chemiluminescence could be demonstrated (75 _+ 79 cpm * 103 (basal), 567 ___ 711 cpm * 103 (PMA) in the pneumonia group (immunocompetent + immunocompromised patients) versus 22 _+ 5 cpm * 103 (basal), 60 _+ 21 cpm * 103 (PMA) in the age matched control group, p < 0.05). This is mainly due to the lavage neutrophil fraction with the percentage of neutrophils in BAL correlating strongly with PMA-stimulated luminol enhanced chemiluminescence (r = 0.68, p < 0.05). Spontaneous luminol enhanced chemiluminescence correlated significantly with interleukin-8 concentration in the supernatants of AM (Figure 2 ). In contrast, there was no significant difference regarding lucigenin enhanced chemiluminescence betweenpneumonia patients and controls (120 + 189 cpm * 10~(basal), 278 ± 222 cpm * 103 (PMA) in the pneumonia group versus 68 + 34 cpm * 103 (basal), 173 _+ 101 cpm * 103 (PMA) in the control group, p = NS). 
Bronchoalveolar Lavage Proteins
Correlation between Interleukin-8 Concentrations and MiCrobiological Parameters
With regard to gas exchange we found a decrease of arterial oxygen tension in patients as compared to healthy control subjects ( p < 0.05). Interestingly, a negative correlation could be established between macrophage interleukin-8 secretion and the arterial pO e at the time of BAL (Figure 3) . No correlation between BALF interleukin-8 levels and arterial pO 2 existed. To elucidate the possible effect of bacterial antigen quantity on the interleukin-8 release of alveolar macrophages, we subdivided our patients according to the results of quantitative microbiological cultures. Patients with 104 or more CFU of one pathogen per ml of lavage fluid were compared to those with either less CFU/ml or nonspecific microbiological findings (mixed throat flora).
Comparing these two groups we found significantly higher interleukin-8 levels in BALF (7.5 ng/ml + 17 vs 0.44 ng/ml + 1, p < 0.05) and in alveolar macrophage supernatants in patients with positive microbiological results (Figure 4 ).
Discussion
The main result of this study is that during community-acquired pneumonia alveolar macrophages release high amounts of interleukin-8, thereby triggering neutrophil accumulation and activation with respect to spontaneous chemiluminescence in the alveolar compartment. These results are in accordance with recently published reports demonstrating high interleukin-8 levels in bronchoalveolar lavage fluid (BALF) in neutrophil alveolitis of other origin [9, 10, 21] , mostly in critically ill patients with ARDS requiring mechanical ventilation and with high mortality in those study cohorts [11, 13, 22] . In contrast, we concentrated on nonventilated pneumonia patients. In addition, most current research was performed using only BALF to quantify cytokine levels in the pulmonary compartment [11, 13] . With the use of BALF a variable dilution error has to be considered, which is due to the increased capillary leakage in lung inflammation of bacterial pneumonia [23] . In accordance with previous studies, this phenomenon is reflected by high albumin levels in BALF of our pneumonia patients as compared to both control groups [23] . Furthermore, cytokine production from many different cell populations (e.g. alveolar macrophages, neutrophils, endothelial and epithelial cells) will be summarized. Although alveolar macrophages are the primary source for interleukin-8 in lung inflammation [9, 13, 25] , all of these cells are able to produce interleukin-8 [26, 27] . The additional objective for using isolated alveolar macrophages was that alveolar macrophages provide first line contact with the invading microorganism in vivo, resulting in the release of recruiting signals for neutrophils, among them interleukin-8 [9] . The possible ex vivo stimulation by adherence on plastic and some unavoidable contamination by neutrophils had to be taken into account. The fact that we could not demonstrate a correlation between interleukin-8 and neutrophil count in BAL is in agreement with other investigators [10, 11, 22] , who discussed the importance of other chemotactic mediators in the network of phagocyte activation in the lung. Furthermore, since both parameters were determined at one time point in the course of inflammatory events, the sequence in which macrophage interleukin-8 release is followed by neutrophil influx cannot be reflected. With regard to neutrophil activation we found a significant correlation between alveolar macrophage interleukin-8 release and oxidative response of alveolar neutrophils. The respiratory burst of pulmonary phagocytes is the central part of the nonspecific host response to pathogenic microorganisms [1, 16] . From our data we cannot distinguish whether neutrophil chemiluminescence is due to stimulation by interleukin-8, or bacteria or both. Considering current knowledge, it seems likely that interleukin-8 has a priming effect on the PMN oxidative response to triggering signals such as bacterial cell wall products [28] [29] [30] . Accordingly, in our patients we demonstrated a clear relationship between the bacterial load in the alveolar space and local interleukin-8 concentration as quantified in BALF and in alveolar macrophage supernatants. Although the mechanisms of host cell activation differ between gram-positive and gram:negative bacteria, the cascade finally leads to activation of cytokine release, expression of their receptors and upregulation of adhesion molecules on the cell surface. In our study population with predominant gram-negative infections, no difference between the various pathogens could be established, however, this type of investigation would require larger patient groups.
With regard to impairment of gas exchange, we demonstrated a significant negative correlation between macrophage interleukin-8 release and the arterial pO 2 at the time of bronchoscopy. This is an interesting observation, since distribution of lung infection as assessed by chest radiograph differed markedly in Our patients. Considering a recently published report demonstrating unilateral upregulation of interleukin-8 in BALF of patients with lobar pneumonia [31] , this phenomenon cannot simply be explained by bronchogenic transfer of cytokines into noninfected parts of the lung. However, it might be possible that in bacterial pneumonia activation of the pulmonary immune system triggers recirculation and distribution of activated immune cells into the affected organ leading to local inflammation, endothelial cell damage and interstitial edema. Summarizing our findings, we could demonstrate that in bacterial pneumonia release of interleukin-8 by alveolar macrophages and other cells plays a central role in host response. This is followed by neutrophil influx and activation, which leads on the one hand to clearing of pathogenic microorganisms, and on the other hand to lung injury and organ malfunction: Larger patient groups and longterm follow-up studies are needed to evaluate the possible prognostic significance of these data.
